Home / Press Releases / Neuralstem Awarded Phase I SBIR Contract to Support Research into Neural Stem Cell Therapy for Severe Traumatic Brain Injury

Neuralstem Awarded Phase I SBIR Contract to Support Research into Neural Stem Cell Therapy for Severe Traumatic Brain Injury

GERMANTOWN, Md., June 11, 2018 (GLOBE NEWSWIRE) — Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced that it has been awarded a Phase I Small Business Innovation Research…

Check Also

Osisko Metals Releases Pine Point In-Pit Inferred Resource: 38,400,000 Tonnes Grading 6.58% ZnEq

MONTREAL, Dec. 06, 2018 (GLOBE NEWSWIRE) — Osisko Metals Incorporated (the “Company” or “Osisko Metals”) (TSX-V: OM; FRANKFURT: OB51) is pleased to announce an updated Inferred Mineral Resource Estimate (“MRE”) for its 100% owned Pine…